Business · 22/08/2000Updated: 10/17/2026 · 1 min read
FDA's Pregnancy Labeling Subcommittee to Meet on October 17, 2024, to Discuss Reproductive Health Drugs
Summary
The FDA's Pregnancy Labeling Subcommittee Advisory Committee for Reproductive Health Drugs will convene on October 17, 2024, to discuss and provide recommendations on labeling requirements for reproductive health drugs.